MELISSA PEW: Open Payments
NPI 1508145582 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 24 payments from 10 companies in 2025. Trend: 2023 $463 · 2024 $856 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $141 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| ABBVIE INC. | 4 | $75 |
| Ipsen Biopharmaceuticals, Inc | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $15 |
| TerSera Therapeutics LLC | 1 | $15 |
Products named: IBSRELA, VOWST, IQIRVO, TREMFYA, DUPIXENT, MAVYRET, ZENPEP, VELSIPITY.
Industry payments across MT — which companies pay providers there.
